Zentalis Pharmaceuticals (ZNTL)'s 30-day implied volatility (IV30) was 81.2% at the close on October 27, 2026, down from 83.9% the day before, against a 52-week range of 52.5% to 184.5%. Its 20-day historical volatility was 75.9%.
Data as of October 27, 2026.